This transparency may help patients understand pricing without surprise fees
"Lilly's phase 2 retatrutide results published in The New England Journal of Medicine show the investigational molecule achieved up to 17.5% mean weight reduction at 24 weeks in adults with obesity and overweight"
Not for sale as a drug or pharmaceutical product
Regular monitoring of body composition, rather than just overall weight loss, may also be beneficial in ensuring a balanced and healthy weight reduction
Retrieved March 10, 2026, from 13 Skipworth, W
Lawsuits describe patients suffering from persistent gastrointestinal symptoms, including severe nausea, vomiting, and impaired stomach emptying